Standard BioTools
LAB
LAB
100 hedge funds and large institutions have $229M invested in Standard BioTools in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
Holders
100
Holding in Top 10
–
Calls
$1.14M
Puts
$1.01M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$9.14M | |
| 3 | +$3.5M | |
| 4 |
Neuberger Berman Group
New York
|
+$2.75M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.72M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$6.62M | |
| 3 | -$5.68M | |
| 4 |
Goldman Sachs
New York
|
-$4.9M |
| 5 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$2.91M |